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Res Syn Meth. 2017;1–8.Authors and indexers are increasingly including terms for adverse drug effects in
the titles, abstracts, or indexing of records inMEDLINE andEmbase. However, it
is not clear if this is the same for studies with nondrug adverse effects data.
We therefore assessed the feasibility of using adverse effects terms when
searching MEDLINE or Embase to retrieve papers of nondrug adverse effects.
A collection of papers that reported data on nondrug adverse effects was sought
from included studies of systematic reviews. Each included study was analysed
to ascertain whether the corresponding record in MEDLINE and Embase
included adverse effects terms in the title, abstract, or indexing.
From 9129 records screened from DARE, 30 reviews evaluating nondrug
adverse effects met our inclusion criteria. From these, 635 unique papers were
included in our analysis.
Sensitive searches for adverse effects required generic and specific named adverse
effects terms using the title, abstract, and indexing. Records relating to surgical
interventionsweremore likely to contain adverse effects terms than records relat-
ing to nonsurgical interventions. Using any adverse effects terms in the title,
abstract or indexing in MEDLINE and Embase would have identified an average
of 94% of papers on surgical adverse effect interventions per systematic review
and 72% of papers on nonsurgical adverse effects per systematic review.
Hence, while a generic nondrug adverse effect search filter may not yet be feasible,
a filter for the adverse effects of surgical interventions may be within reach.
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An important part of any systematic review is the process
of searching for studies, which needs to be thorough,
transparent, and reproducible.1 This is usually conducted
on a number of databases (such as MEDLINE and- - - - - - - - - - - - - - - - - - - - - - - - - -
reative Commons Attribution Lice
blished by John Wiley & Sons Ltd.Embase) as well as nondatabase resources (such as refer-
ence checking). Systematic reviews should use search
strategies that aim to identify as many relevant papers as
possible. Searches need to be highly sensitive and aimed
at identifying all the possible studies on a particular topic.
However, highly sensitive searches are often associated- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
nse, which permits use, distribution and reproduction in any medium, provided the
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2 GOLDER ET AL.with low precision, whereby, lots of irrelevant records are
also identified. To improve efficiency, search filters with
predefined combinations of search terms have been devel-
oped to identify topics (such as paediatrics2,3 or research
designs such as randomised controlled trials4) that are of
wide interest. However, searching for information on
adverse effects is challenging because adverse effects are
often secondary or even tertiary outcomes and the termi-
nology used can be inconsistent.
As studies containing adverse effects data are particu-
larly difficult to search for, creating a search filter in this
area would be highly desirable. Although any intervention
(be it drug, device, surgical, or behavioural) can have
adverse effects, adverse effects search filters have focused
primarily on drug interventions5‐10. There is increasing rec-
ognition that these filters do not perform well for nondrug
adverse effects11,12—such as medical devices and surgical
interventions. It has therefore been proposed that different
combinations of search terms would be required.12,13 How-
ever, the feasibility of creating search filters for the adverse
effects of nondrug interventions has yet to be established. If
adverse effects search terms are present in the biblio-
graphic records, these terms could potentially be used in
a database search strategy or used to create a search filter.12
We aimed to assess the feasibility of creating validated
search filters for nondrug interventions in MEDLINE and
Embase. This is the first step towards creating nondrug adverse
effects search filters or enabling searchers to create their own
combinations of adverse effects search terms for their review.
Although feasibility can be subjective, for our purposes we
adopted a definition of a combination of terms that would
identify greater than 90% of relevant records indexed.142 | METHODS
A collection of papers that reported data on the frequency
of adverse effects of nondrug interventions was sought from
the included studies of systematic review of adverse effects.2.1 | Selection of systematic reviews
Systematic reviews of adverse effects were identified by
manually screening all records published in 2014 in the
Database of Abstracts of Reviews of Effects (DARE) (via
the Centre for Reviews and Dissemination web site, April
2015). No automated search strategy was implemented, as
previous research has indicated that even very broad search
strings would miss relevant records.15 The DARE database
was chosen because it was the most accessible major collec-
tion of systematic reviews of health care interventions.
DARE was compiled through rigorous monthly searches
of bibliographic databases, including MEDLINE andEmbase, as well as handsearching of key journals, grey lit-
erature, and regular searches of the Internet. It also con-
tains all Cochrane reviews, both new and updated. DARE
ceased production in March 2015 but continues to be avail-
able in archive format. A systematic review was considered
eligible for inclusion if
a. Adverse effect(s) for a nondrug intervention were the
primary outcome.
b. Generic adverse effects search terms or specified
named adverse effects search terms had not been used
by the review authors. This enabled an unselected
cohort to be built, where relevant articles were not
chosen because of the presence of adverse effects
terms. Typically, such reviews would have relied on
search terms for population/condition and interven-
tion only.
c. The search included either handsearching or refer-
ence checking in addition to database searches. This
may identify additional records available in
MEDLINE and Embase but not identified by the
search strategy used by the reviewers.
Criteria b and c were applied in previous research on
adverse drug effects searching by Derry et al16 and Golder
and Loke.5 Maintaining this consistency with previous
research methods also ensured that we were able to make
direct comparisons with such research. The author and
another researcher independently screened titles and
abstracts in DARE and selected full articles for inclusion.
Any discrepancies between the researchers were resolved
by discussion and consensus.2.2 | Selection of primary studies
The included references from the systematic reviews were
then used to create a gold standard set of records. Full‐text
articles were checked to confirm the presence of adverse
effects data that had been used in the systematic review.
Papers that had been included in more than one systematic
review were only included once.
The first stage of the analysis was to check whether
each paper was contained in MEDLINE and/or Embase,
and this was done by using several search iterations as nec-
essary using author names and/or words from the title.2.3 | Adverse effects terms in the database
records
For each database, the available records were checked by
2 reviewers (S.G. and Y.L.) to ascertain if
GOLDER ET AL. 31. The authors mentioned terms synonymous with
“adverse effects” in the title or abstract, potentially
enabling the paper to be found in an electronic
search. Adverse effects terms, such as “adverse
events,” “side effects,” “tolerated,” and “unwanted
effects” were accepted.
2. The authors mentioned specific named adverse effects
terms (such as “headache” or “cancer”) in the title or
abstract. The terms were accepted based on the
adverse effects included in the systematic review.
For example, for a systematic review on cancer as
an adverse effect, only cancer‐related terms were
accepted. This part of the analysis was only conducted
on included studies from reviews for a specific
named adverse effect. As specific named adverse
effects may be unknown to the searcher of a safety
profile review at the time of searching.
3. The papers had been indexed (using subject headings
or subheadings) with relevant terms for adverse
effects, potentially enabling the paper to be found in
an electronic search. Adverse effects terms were
accepted on the basis that they could be considered
synonymous with “adverse effects” such as side
effects or “adverse effects (ae).”
4. The papers had been indexed with specific named
adverse effects terms. The terms were accepted based
on the adverse effects included in the systematic
review. For example, for a systematic review on can-
cer as an adverse effect, only cancer‐related terms
were accepted. This part of the analysis was only con-
ducted on included studies from reviews for a specific
named adverse effect.
Any disagreements between the reviewers as to whether
a term was synonymous with “adverse effects” or a specific
named adverse effect were resolved by discussion and con-
sensus. We also referred to previously accepted terms used
in research on systematic reviews of drug interventions.5,162.4 | Analysis
The percentage of papers identified via adverse effects terms
in the title and abstract or indexing were recorded for
MEDLINE alone, Embase alone, or a combination of both
MEDLINE and Embase. In reviews of specific named
adverse effects, the results were calculated separately with
the use of specific named adverse effects and generic
adverse effects terms as well as a combination of both. This
enabled a comparison between MEDLINE and Embase,
between textword and indexing search terms, and between
generic and specific named adverse effect terms.
The results were calculated as a whole for all the
included papers in the systematic reviews and again foreach individual systematic review. This enabled any pat-
terns of retrieval and any variance between different sys-
tematic reviews to be identified. The systematic reviews
were categorised depending on the intervention
evaluated.
To ascertain whether a search filter could be feasible,
we used the measure of the percentage of relevant papers
identified using a combination of all available adverse
effects terms (also known as sensitivity). In general, the
acceptable level of sensitivity of combinations of adverse
effects search terms or a search filter is subjective and
dependent on the topic of the search.6 However, for sys-
tematic review purposes, acceptable sensitivity tends to
be defined as greater than 90%.14 We therefore used this
threshold in our analysis.
The results were then compared with previous studies
that evaluated the presence of adverse effects search terms
for drug interventions.5,16 To ascertain whether a search
filter for nondrugs could be comparable in performance
to drug adverse effects filters.3 | RESULTS
3.1 | Systematic reviews included
From 9129 DARE records screened, 451 full reports were
retrieved and of these, 348 reviews were about adverse
effects with 111 evaluating nondrug interventions. Sixty‐
four of these 111 reviews were excluded as they did not
include any adverse effects terms in their search strate-
gies, and 17 of these were excluded as they did not check
references lists or conduct hand searches. Thirty system-
atic reviews, therefore, met our inclusion criteria
(Figure 1: flow diagram). Nineteen of the reviews evalu-
ated a surgical intervention and 11 evaluated a nonsurgi-
cal intervention. As nearly two‐thirds of the reviews were
of surgical interventions, the papers from the surgical and
nonsurgical reviews were analysed separately. The non-
surgical interventions varied; 4 reviews were of physical
therapy—(such as weight training or tai chi), 4 of physical
interventions—(such as acupuncture or radiation ther-
apy), 2 were of dentistry and 1 of a medical device
(catheters).
The majority of the reviews (77%, 23/30) could be con-
sidered hypothesis generating reviews whereby the broad
safety profile of an intervention was considered, rather
than focusing down on a narrow set of particular out-
comes. Six reviews (5 of which were of surgical interven-
tions) considered a pre‐specified set of adverse effects
(such as neurological, cardiovascular and cerebrovascular
events, genitourinary or biliary complications, or infec-
tions). One review (of a surgical intervention) evaluated
a specific pre‐specified adverse effect—perforation.
FIGURE 1 Flow diagram [Colour figure can be viewed at
wileyonlinelibrary.com]
TABLE 1 Average percentage of records per systematic review with a
Intervention
(Number of
Systematic Reviews)
Type of Adverse Effects
Terms (Number of
Systematic Reviews)
Title or
Adverse
Terms (
Surgical (n = 19) Generic (n = 19) MEDLIN
77% (27%
Embase
78% (33%
Specific (n = 6) MEDLIN
60% (11%
Embase
61% (16%
Generic or specific (n = 19) MEDLIN
82% (47%
Nonsurgical (n = 11) Generic (n = 11) MEDLIN
48% (10%
Embase
47% (10%
Specific (n = 1) MEDLIN
43%
Embase
39%
Generic or specific (n = 11) MEDLIN
50% (10%
4 GOLDER ET AL.3.2 | Primary studies included
A total of 644 papers were included in the 30 systematic
reviews (range 3 to 86 papers per review). Nine included
studies, however, were duplicate papers (contained in
two systematic reviews), leaving 635 studies (358 from
surgical intervention reviews and 277 from other nondrug
reviews) for analysis.3.3 | Availability in MEDLINE and
Embase
Of the 635 studies, 26 were not available on MEDLINE
and 32 were not available in Embase. Of the 609 papers
available in MEDLINE, 352 were from surgical interven-
tion reviews and 257 from nonsurgical reviews. Of the
603 papers available on Embase, 348 were from surgical
intervention reviews and 255 from nonsurgical reviews.
Each MEDLINE and Embase record was examined for
the existence of adverse effects terms in the title, abstract,
or indexing. A list of accepted terms identified in at least
one paper is given in Table S1.3.4 | Average percentage of papers with
adverse effects terms per systematic review
The average percentage of papers per systematic review
containing adverse effects terms in the title, abstract, or
indexing is summarised in Table 1 (details for individual
systematic reviews are listed in Tables S2 and S3).dverse effects terms
Abstract
Effects
Range)
Indexing Adverse
Effect Terms
(Range)
Title, Abstract, or
Indexing Adverse
Effects Terms (Range)
E
‐100%) 63% (33%‐100%) 88% (47%‐100%)
‐100%) 73% (47%‐100%) 89% (47%‐100%)
E
‐100%) 35% (0%‐82%) 64% (11%‐100%)
‐100%) 59% (16%‐100%) 66% (22%‐100%)
E and Embase
‐100%) 87% (53%‐100%) 94% (67%‐100%)
E
‐97%) 49% (5%‐97%) 66% (40%‐100%)
‐97%) 43% (15%‐82%) 66% (40%‐100%)
E
17% 43%
45% 55%
E and Embase
‐97%) 60% (20%‐97%) 72% (40%‐100%)
GOLDER ET AL. 5While the percentage of adverse effects terms in the
title and abstract in MEDLINE and Embase is similar,
the percentage of records in Embase with indexing
terms for adverse effects terms is generally higher
(Table 1). In addition, it can be seen from Table 1 that
papers for surgical interventions are more likely to con-
tain terms for adverse effects than papers for nonsurgi-
cal interventions. Generic adverse effects terms also
captured a higher percentage of papers than specific
adverse effects terms.
Table 2 summarises these results for a combined
search of both MEDLINE and Embase and presents a
comparative analysis with studies of drug interven-
tions.5,16 In respect to papers on surgical interventions, a
combined search of both MEDLINE and Embase
retrieved an average of 94% (67% to 100%) of the included
studies available. This is a similar percentage to the most
recent drug intervention study, 92% (43% to 100%).5
In the case of nonsurgical interventions, a combined
search of both MEDLINE and Embase retrieved an aver-
age of 72% (40% to 100%) of the included studies available.TABLE 2 Average percentage of records per systematic review with a
Intervention
(Number of
Systematic Reviews)
Title or Abstract
Adverse Effects
Terms in MEDLINE
or Embase (Range)
Drug16 (n = 4) 59% (49%‐69%)
Drug5 (n = 26) 69% (21%‐100%)
Surgical (present study) (n = 19) 82% (47%‐100%)
Nonsurgical (present study) (n = 11) 50% (10%‐97%)
TABLE 3 Adverse effects terms in the title, abstract, or indexing of re
Intervention
Database (Number of
Records)
Title or
Abstract Ind
Generic adverse effe
Surgical MEDLINE (n = 352) 275 (78%) 99 (
Embase (n = 348) 275 (79%) 180
Nonsurgical MEDLINE (n = 257) 127 (49%) 8 (3
Embase (n = 255) 127 (50%) 36 (
Specific adverse effe
Surgical MEDLINE (n = 208) 85 (41%) 39 (
Embase (n = 208) 88 (42%) 81 (
Nonsurgical MEDLINE (n = 21) 9 (43%) 4 (1
Embase (n = 22) 9 (41%) 10 (
Generic or specific a
Surgical MEDLINE (n = 352) 292 (83%) 108
Embase (n = 348) 288 (83%) 191
Nonsurgical MEDLINE (n = 257) 129 (50%) 9 (4
Embase (n = 255) 129 (51%) 36 (This is lower than in the most recent study on drug inter-
ventions, 92% (43% to 100%),5 and lower than the surgical
interventions, 94% (67% to 100%) (Table 2). However, this
is comparable to the older drug intervention study in
which adverse effects search terms retrieved 77% of rele-
vant records (range 69%‐83%).
Overall, a combined search using terms in the title,
abstract, or indexing run in both MEDLINE and Embase
would have failed to retrieve 28% of papers across all the
nonsurgical systematic reviews and 6% of papers across
the surgical systematic reviews.3.5 | Overall percentage of adverse effects
terms
In addition to an analysis of the papers per systematic
review with adverse effects terms, we also conducted an
overall analysis of the cohort of records (Table 3).
Generic adverse effects terms (such as side effect or
adverse event) may be used in either systematic reviews
of a safety profile of an intervention or reviews of adverse effects terms
Indexing Adverse
Effect Terms in
MEDLINE or
Embase (Range)
Title, Abstract, or
Indexing Adverse Effects
Terms in MEDLINE or
Embase (Range)
64% (54%‐76%) 77% (69%‐83%)
90% (14%‐100%) 92% (43%‐100%)
87% (53%‐100%) 94% (67%‐100%)
60% (20%‐97%) 72% (40%‐100%)
cords of all included studies in MEDLINE and Embase
exing Subheadings
Indexing or
Subheadings
Any Search
Field
cts terms
28%) 168 (48%) 222 (81%) 314 (89%)
(49%) 212 (61%) 262 (75%) 315 (90%)
%) 116 (45%) 120 (47%) 166 (65%)
14%) 89 (35%) 104 (41%) 164 (64%)
cts
19%) 89 (43%)
39%) 94 (45%)
9%) 10 (48%)
45%) 12 (55%)
dverse effects terms
(31%) 168 (48%) 231 (65%) 324 (92%)
(55%) 212 (61%) 276 (79%) 319 (92%)
%) 116 (45%) 121 (47%) 167 (65%)
14%) 89 (35%) 104 (41%) 164 (64%)
6 GOLDER ET AL.specific named adverse effect. Overall surgical interven-
tion papers are more likely to contain generic adverse
effects terms in the title and abstract and indexing
(Table 3) (89% versus 66%).
The use of specific named adverse effects search terms
could only be assessed in systematic reviews of specific
named adverse effects. Overall specific adverse effects
terms in title and abstract were similar in surgical and
nonsurgical intervention papers and fairly low (Table 3).
Using any adverse effects terms in the title, abstract, or
indexing would have identified 92% of relevant references
in MEDLINE and 92% in Embase for papers on surgical
intervention but only 65% in MEDLINE and 64% in
Embase of papers on nonsurgical interventions (Table 3).4 | DISCUSSION
We found substantial differences in the prevalence of
adverse effects terms in studies of nondrug interventions.
While the majority of adverse effects studies on surgical
interventions can be retrieved by using both Embase
and MEDLINE, over a quarter of adverse effect studies
on nonsurgical interventions are likely to be missed with
this method. Adverse effect terms performed better in
studies of surgical interventions compared to those of
nonsurgical interventions. Studies of surgical interven-
tions were more likely to have free text terms such as com-
plication, complications, safe, safely, and safety, or
indexing terms such as complication (EMTREE), patient
safety (EMTREE), and safety (EMTREE) and floating sub-
headings such as adverse effects (ae) and complications (co)
in MEDLINE and complication (co) in Embase. The over-
all figures for the surgical intervention studies were close
to that seen with recent studies of drug interventions. In
contrast, nondrug, nonsurgical interventions had a much
lower occurrence of generic adverse effects related terms.
This has important implications for development of
search filters of nondrug interventions or the use of
adverse effects terms in nondrug reviews.
These results suggest that a search filter for surgical
adverse effects may be feasible. As adverse effects terms
are frequently present in the bibliographic records, search
strategies could be successfully formulated using text min-
ing solutions.
We were also able to investigate the use of generic and
specific terms and using particular search fields when
searching. Interestingly, the records of studies of surgical
interventions and nonsurgical interventions both
contained similar low levels of specific adverse effects
terms in the title, abstract, or indexing (among studies from
reviews of a specific adverse effect). This suggests that
using specific adverse effects (without generic adverseeffects) may only capture approximately half of all the rel-
evant records. Reassuringly generic adverse effect terms
performed much better. However, as searching for generic
and specific search terms gave a higher yield than
searching for either alone, a sensitive search should where
possible contain both types of terms. In addition, sensitive
searching for adverse effect should use terms in title/
abstract and indexing as this gave a higher yield than
searching in title/abstract or indexing alone.
It is debatable whether the creation of a generic
adverse effects search filter covering all nondrug interven-
tions is either feasible or useful. The sensitivity of such a
filter is unlikely to reach acceptable levels for a systematic
review. Filters categorised more specifically by type of
intervention, however, may be feasible. For most types
of interventions, the number of primary papers we identi-
fied was too small to assess the feasibility of a search filter.
For example, there was only 30 included papers (from one
systematic review) that evaluated medical devices. There
was, however, 358 included papers on surgical interven-
tions from 19 systematic reviews. The results suggest that
a filter specifically targeted at adverse effects of surgical
interventions may be plausible, given that a sensitivity of
over 90% may be achievable.
The reasons for the lack of search terms for nonsurgical
nondrug reviews may lie in the considerable diversity of
nonsurgical, nondrug interventions such as dentistry, med-
ical devices, physical interventions, and physical activity.
This is very likely to lead to lack of standardisation of terms
among the researchers. Also, adverse effects may not be
considered to be an important part of those research
areas, and so the terms are not given any prominence
in the title, abstract, or indexing stages. Equally, the
interventions may be perceived as very safe, and so only
small amount of adverse effects are reported and subse-
quently indexed.4.1 | Limitations
The limited number of systematic reviews meeting our
inclusion criteria means that it is not feasible to explore
the feasibility of further search filters for different types
of interventions. Another limitation is that the reliability
of the results in this study is dependent to some extent
on the quality of the search processes and sifting con-
ducted within each included systematic review, which
is difficult to judge. However, each review met the
DARE quality inclusion criteria and had reported their
search strategy in enough detail to ascertain that no
adverse effects terms had been used and whether
handsearching or reference checking had been con-
ducted. The handsearching or reference checking may
GOLDER ET AL. 7also help compensate for any limitations in the search
strategies.
We excluded specific named adverse effects that are
frequently related to surgery, for example, postoperative
infection, postoperative pain, surgical infection, and sur-
gical wound infection unless specified as the focus of the
systematic review. If these terms were to be included, this
may increase the sensitivity of the surgical intervention
searches further.5 | CONCLUSION
Development of search filters for the adverse effects of
surgical interventions with acceptable sensitivity for sys-
tematic reviews is a possibility. A future research priority
should be to create search filters for adverse effects of sur-
gical interventions in both MEDLINE and Embase.
The feasibility of developing filters for other types of
nonsurgical interventions, such as medical devices, should
also be undertaken using a much bigger sample size.5.1 | What is already known
Searching for adverse effects of nondrug interventions is
difficult.5.2 | What is new
Searching for adverse effects of surgical interventions (with
over 90% sensitivity) is feasible with adverse effects terms.
Searching for adverse effects of nonsurgical nondrug
interventions (with over 90% sensitivity) is not feasible
with adverse effects terms; however, more research is
needed into specific interventions, such as medical
devices.5.3 | Potential impact for RSM readers
outside the authors' field
Searches for the adverse effects of surgical interven-
tions could be made easier by the development of a
search filter.
The addition of search terms for adverse effects of sur-
gical interventions to searches could make the number of
records to screen for a systematic review more manage-
able and still retrieve over 90% of the relevant papers.ACKNOWLEDGEMENTS
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